Exogenous Volatile Organic Compound (EVOC<sup>®</sup>) Breath Testing Maximizes Classification Performance for Subjects with Cirrhosis and Reveals Signs of Portal Hypertension

Exogenous Volatile Organic Compound (EVOC<sup>®</sup>) Breath Testing Maximizes Classification Performance for Subjects with Cirrhosis and Reveals Signs of Portal Hypertension

<b>Background:</b> Cirrhosis detection in primary care relies on low-performing biomarkers. Consequently, up to 75% of subjects with cirrhosis receive their first diagnosis with decompensation when causal treatments are less effective at preserving liver function. We investigated an unpr...

Full description

Bibliographic Details
Main Authors: Giuseppe Ferrandino, Federico Ricciardi, Antonio Murgia, Iris Banda, Menisha Manhota, Yusuf Ahmed, Kelly Sweeney, Louise Nicholson-Scott, Lucinda McConville, Olga Gandelman, Max Allsworth, Billy Boyle, Agnieszka Smolinska, Carmen A. Ginesta Frings, Jorge Contreras, Claudia Asenjo-Lobos, Viviana Barrientos, Nataly Clavo, Angela Novoa, Amy Riviotta, Melissa Jerez, Luis Méndez
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomedicines
Subjects:
breath biopsy
volatile organic compounds
functional diagnostics
non-invasive
MELD
Online Access:https://www.mdpi.com/2227-9059/11/11/2957

Internet

https://www.mdpi.com/2227-9059/11/11/2957

Similar Items